Here, we show that chronic lung disease, including CF, creates a permissive environment for TGF-β1-miRNA cross-talk, leading to selective recruitment of validated CFTR inhibitors to RISC and decay of CFTR mRNA. The gene discussed is TGFB1; the disease is cystic fibrosis.